Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
177
-
Total 13F shares, excl. options
-
34.9M
-
Shares change
-
-401K
-
Total reported value, excl. options
-
$1.16B
-
Value change
-
-$13.1M
-
Put/Call ratio
-
0.84
-
Number of buys
-
92
-
Number of sells
-
-69
-
Price
-
$33.19
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q1 2022
203 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q1 2022.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.9M shares
of 51.1M outstanding shares and own 68.21% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.59M shares), JPMORGAN CHASE & CO (4.72M shares), VANGUARD GROUP INC (4.07M shares), STATE STREET CORP (2.65M shares), Redmile Group, LLC (1.98M shares), RTW INVESTMENTS, LP (1.85M shares), Aquilo Capital Management, LLC (1.12M shares), DIMENSIONAL FUND ADVISORS LP (779K shares), FIRST MANHATTAN CO (696K shares), and GEODE CAPITAL MANAGEMENT, LLC (686K shares).
This table shows the top 177 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.